RedHill Biopharma Ltd - ADR (NASDAQ:RDHL) shares are trading higher by 68 cents (8 percent) at $10.15 in Wednesday's session.
The catalyst for the rally is positive Phase III results with BEKINDA for acute gastroenteritis.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
See Also: RedHill Biopharma CEO Talks Steering His Company Through A Year Heavy With Potential Catalysts
After a higher open, RedHill retreated but found support just above the top of Tuesday's range ($9.71) at $9.80 and resumed its move higher. The ensuing rally has taken the stock to $10.64, which coincides with it April 21 high of $10.64.
It's now attempting to post its first close over $10.00 since May 23, when it ended that session at $10.11.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.